PL
POST LEONARD E
Director
BoardM
Insider track record
Board DirectorAcross 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by POST LEONARD E, Director. Officer active across 3 companies, notably uniQure N.V.. In total, 21 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €77k. History available since 24 February 2022. The latest transaction was filed on 4 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
5,000 sharesCommon StockSEC:0001193125-26-282861:0
5,000 sharesCommon StockSEC:0001193125-26-282861:1
5,000 sharesCommon StockSEC:0001193125-26-279543:0
5,000 sharesCommon StockSEC:0001193125-26-279543:1
1,000 shares@ US$0.600.0000% mcap1.0% of flowCommon StockSEC:0001193125-26-259705:0
1,000 shares@ US$54.500.0010% mcap91.4% of flowCommon StockSEC:0001193125-26-259705:1
1,000 shares@ US$0.6013.6% of flowCommon StockSEC:0000950170-25-076339:0
1,000 shares@ US$0.6013.5% of flowCommon StockSEC:0000950170-25-060145:0
1,000 shares@ US$0.6014.1% of flowCommon StockSEC:0000950170-25-041265:0
1,000 shares@ US$0.6014.7% of flowCommon StockSEC:0000950170-25-023182:0
1,000 shares@ US$0.6015.0% of flowCommon StockSEC:0000950170-25-005359:0
1,000 shares@ US$0.6014.6% of flowCommon StockSEC:0000950170-24-137319:0
1,000 shares@ US$0.6014.5% of flowCommon StockSEC:0000950170-24-134261:0
8,080 shares0Ordinary SharesSEC:0000904454-24-000397:0
2,222 shares@ US$5.1435.8% of flowOrdinary SharesSEC:0000904454-24-000385:0
8,700 shares0Ordinary SharesSEC:0000904454-23-000400:0
389 shares@ US$19.7324.5% of flowOrdinary SharesSEC:0000899243-23-006594:0
8,000 shares0Common StockSEC:0001209191-22-044302:0
9,080 shares0Ordinary SharesSEC:0000904454-22-000362:0
795 shares@ US$16.640.0008% mcap100.0% of flowOrdinary SharesSEC:0000904454-22-000221:0
1,534 shares0Ordinary SharesSEC:0000904454-22-000199:0
About POST LEONARD E
Leonard E. Post is a Board Member at uniQure N.V. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of uniQure. His experience in the biopharmaceutical sector allows him to provide valuable insights into innovation and growth challenges.